Vascular deconjugation of quercetin glucuronide: The flavonoid paradox revealed?

Molecular Nutrition and Food Research

Volumn 55, Issue 12, 2011, Pages 1780-1790

  Menendez, Carmen ^a,b   Dueñas, Montserrat ^c   Galindo, Pilar ^d   González Manzano, Susana ^c   Jimenez, Rosario ^d   Moreno, Laura ^a,b   Zarzuelo, Maria José ^d   Rodríguez Gómez, Isabel ^d   Duarte, Juan ^d   Santos Buelga, Celestino ^c   Perez Vizcaino, Francisco ^a,b  

^a SCHOOL OF MEDICINE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

Blood pressure; Glucuronide; Metabolism; Quercetin; Vasodilation

Indexed keywords

BETA GLUCURONIDASE; BETA GLUCURONIDASE INHIBITOR; BETA-GLUCURONIDASE INHIBITOR; CARDIOVASCULAR AGENT; DRUG DERIVATIVE; GLYCOPROTEIN; QUERCETIN; QUERCETIN 3 O GLUCURONIDE; QUERCETIN 3-O-GLUCURONIDE; SACCHARIC ACID; SACCHAROLACTONE;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; DRUG EFFECT; HEART CONTRACTION; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESENTERIC ARTERY; METABOLISM; ORAL DRUG ADMINISTRATION; RAT;

ADMINISTRATION, ORAL; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; GLUCARIC ACID; GLUCURONIDASE; GLYCOPROTEINS; INJECTIONS, INTRAVENOUS; MALE; MESENTERIC ARTERIES; MYOCARDIAL CONTRACTION; QUERCETIN; RATS;

EID: 82955161729     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100378     Document Type: Article

References (29)

1. Hertog, M. G., Feskens, E. J., Hollman, P. C., Katan, M. B., Kromhout, D., Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993, 342, 1007-1011.
2. Sampson, L., Rimm, E., Hollman, P. C., de Vries, J. H., Katan, M. B., Flavonol and flavone intakes in US health professionals. J. Am. Diet Assoc. 2002, 102, 1414-1420.
3. Keli, S. O., Hertog, M. G., Feskens, E. J., Kromhout, D., Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch. Intern. Med. 1996, 156, 637-642.
4. Perez-Vizcaino, F., Duarte, J., Flavonols and cardiovascular disease. Mol. Aspects Med. 2010, 31, 478-494.
5. 2. Role in vasodilatation. Cardiovasc. Res. 2007, 73, 424-431.
6. Duarte, J., Perez Vizcaino, F., Utrilla, P., Jimenez, J. et al., Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen. Pharmacol. 1993, 24, 857-862.
7. Perez-Vizcaino, F., Ibarra, M., Cogolludo, A. L., Duarte, J. et al., Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. J. Pharmacol. Exp. Ther. 2002, 302, 66-72.
8. Gryglewski, R. J., Korbut, R., Robak, J., Swies, J., On the mechanism of antithrombotic action of flavonoids. Biochem. Pharmacol. 1987, 36, 317-322.
9. Menendez, C., Jimenez, R., Moreno, L., Galindo, P. et al., Lack of synergistic interaction between quercetin and catechin in systemic and pulmonary vascular smooth muscle. Br. J. Nutr. 2011, 105, 1287-1293.
10. Duarte, J., Perez-Palencia, R., Vargas, F., Ocete, M. A. et al., Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br. J. Pharmacol. 2001, 133, 117-124.
11. Scalbert, A., Williamson, G., Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130, 2073S-2085S.
12. Day, A. J., Mellon, F., Barron, D., Sarrazin, G. et al., Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic. Res. 2001, 35, 941-952.
13. Kawai, Y., Saito, S., Nishikawa, T., Ishisaka, A. et al., Different profiles of quercetin metabolites in rat plasma: comparison of two administration methods. Biosci. Biotechnol. Biochem. 2009, 73, 517-523.
14. Middleton, E., Jr., Kandaswami, C., Theoharides, T. C., The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52, 673-751.
15. Kroon, P. A., Clifford, M. N., Crozier, A., Day, A. J. et al., How should we assess the effects of exposure to dietary polyphenols in vitro? Am. J. Clin. Nutr. 2004, 80, 15-21.
16. Kay, C. D., The future of flavonoid research. Br. J. Nutr. 2010, 104, S91-S95.
17. Lodi, F., Jimenez, R., Menendez, C., Needs, P. W. et al., Glucuronidated metabolites of the flavonoid quercetin do not auto-oxidise, do not generate free radicals and do not decrease nitric oxide bioavailability. Planta Med. 2008, 74, 741-746.
18. Lodi, F., Jimenez, R., Moreno, L., Kroon, P. A. et al., Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis 2009, 204, 34-39.
19. Wright, B., Moraes, L. A., Kemp, C. F., Mullen, W. et al., A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. Br. J. Pharmacol. 2010, 159, 1312-1325.
20. Winterbone, M. S., Tribolo, S., Needs, P. W., Kroon, P. A., Hughes, D. A., Physiologically relevant metabolites of quercetin have no effect on adhesion molecule or chemokine expression in human vascular smooth muscle cells. Atherosclerosis 2009, 202, 431-438.
21. Duenas, M., Mingo-Chornet, H., Joaquin Perez-Alonso, J., Di Paola-Naranjo, R. et al., Preparation of quercetin glucuronides and characterization by HPLC-DAD-ESI/MS. Eur. Food Res. Technol. 2008, 227, 1060-1076.
22. Perez-Vizcaino, F., Cooper, A. C., Corder, R., Fournier, A., Warner, T. D., Rapid degradation of endothelin-1 by an enzyme released by the rat isolated perfused mesentery. Br. J. Pharmacol. 1995, 114, 867-871.
23. Kushinsky, S., Chen, V. L., The inhibition of beta-glucuronidase from bovine liver by 1, 4-saccharolactone. Comp. Biochem. Physiol. 1967, 20, 535-542.
24. Kawai, Y., Nishikawa, T., Shiba, Y., Saito, S. et al., Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: Implication in the anti-atherosclerotic mechanism of dietary flavonoids. J. Biol. Chem. 2008, 283, 9424-9434.
25. da Silva, E. L., Piskula, M. K., Yamamoto, N., Moon, J. H., Terao, J., Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma. FEBS Lett. 1998, 430, 405-408.
26. O'Leary, K. A., Day, A. J., Needs, P. W., Sly, W. S. et al., Flavonoid glucuronides are substrates for human liver beta-glucuronidase. FEBS Lett. 2001, 503, 103-106.
27. Bieger, J., Cermak, R., Blank, R., de Boer, V. C. et al., Tissue distribution of quercetin in pigs after long-term dietary supplementation. J. Nutr. 2008, 138, 1417-1420.
28. Boulton, D. W., Walle, U. K., Walle, T., Fate of the flavonoid quercetin in human cell lines: chemical instability and metabolism. J. Pharm. Pharmacol. 1999, 51, 353-359.
29. van Duynhoven, J., Vaughan, E. E., Jacobs, D. M., Kemperman, R. A. et al., Metabolic fate of polyphenols in the human superorganism. Proc. Natl. Acad. Sci. USA 108, 4531-4538.